- ICH GCP
- US Clinical Trials Registry
- Researchers
- Greece
- Multiple Myeloma
Medical specialists from Greece tagged as investigators in clinical trials studying Multiple Myeloma
Total 30 results
-
Argiris S. SymeonidisSeen in:
- Rio/Patras, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Argiris SymeonidisSeen in:
- Achaia, Patra, University General Hospital of Patras
- Peloponnese, Patra, University Regional General Hospital of Patras
Trials:- NCT03215030 (Principal Investigator)
- NCT04278924 (Principal Investigator)
Conditions: -
Athanasios GalanopoulosSeen in:
- Athens, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Athanasios-Meletios Dimopoulos, ProfessorSeen in:
- Athens, Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)
Trials:- NCT05280275 (Principal Investigator)
-
DelimpasiSeen in:
- Athens, General Hospital of Athens"Evangelismos"
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Dr. Sosana DelimpasiSeen in:
- Attiki, Athens, General Hospital of Athens "Evaggelismos"
Trials:- NCT04414475 (Principal Investigator)
Conditions: -
Efstathios KastritisSeen in:
- Athens, Alexandra General Hospital
- Athens, National and Kapodistrian University of Athens, School of Medicine
- Attica, Athens, Alexandra Hospital , Department of Clinical Therapeutics
Trials:- NCT04131309 (Principal Investigator)
- NCT05879757 (Principal Investigator)
- NCT03405571 (Sub-Investigator)
-
Eirini Katodritou, Dr.Seen in:
- Thessaloniki, Anticancer Hospital of Thessaloniki "Theageneio"
Trials:- NCT05280275 (Principal Investigator)
- NCT05573802 (Principal Investigator)
-
Eirini Katodrytou, MD,Dir.Seen in:
- Thessaloníki, Anticancer Hospital of Thessaloniki "Theageneio", Hematology
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Eirini KatoudritouSeen in:
- Thessaloniki, Theageneion Cancer Hospital
Trials:- NCT04414475 (Principal Investigator)
Conditions: -
Eleftheria HatzimichaelSeen in:
- Ioannina, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Evangelos Terpos, Prof.MDSeen in:
- Athens, General Hospital of Athens "Alexandra, Plasma Cell Dyscrasias Unit
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Evdoxia HatjiharissiSeen in:
- Thessaloniki, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
George VassilopoulosSeen in:
- Larisa, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Ioanna SakellariSeen in:
- Thessaloniki, G. Papanikolaou Hospital
- Thessaloniki, General Hospital of Thessaloniki "G. Papanikolaou"
Trials:- NCT05714969 (Principal Investigator)
- NCT05879757 (Principal Investigator)
-
KatodrytouSeen in:
- Thessaloníki, Theagenion Cancer Hospital
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Konstantinos AnargyrouSeen in:
- Athens, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Maria Roussou, MDSeen in:
- Attica, Athens, Alexandra Hospital , Department of Clinical Therapeutics
Trials:- NCT03405571 (Sub-Investigator)
Conditions: -
Meletios A Dimopoulos, MDSeen in:
- Attica, Athens, Alexandra Hospital , Department of Clinical Therapeutics
Trials:- NCT03405571 (Principal Investigator)
Conditions: -
Meletios A. Dimopoulos, ProfessorSeen in:
- Athens, General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic
Trials:- NCT05573802 (Principal Investigator)
-
Meletios Athanasios DimopoulosSeen in:
- Athens, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT04398680 (Principal Investigator)
Conditions: -
Meletios DimopoulosSeen in:
- Attica, Athens, Alexandra General Hospital of Athens
Trials:- NCT03215030 (Principal Investigator)
Conditions: -
Michail IskasSeen in:
- Thessaloniki, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
PouliSeen in:
- Athens, St Savvas Cancer Hospital
Trials:- NCT05028348 (Principal Investigator)
Conditions: -
Prof. Anargyros SymeonidisSeen in:
- Achaia, Patra, University General Hospital of Patras
Trials:- NCT04414475 (Principal Investigator)
Conditions: -
Prof. Maria GavriatopoulouSeen in:
- Athens, Attiki, General Hospital of Athens "ALEXANDRA"
Trials:- NCT04414475 (Principal Investigator)
Conditions: -
Sosana DelimpasiSeen in:
- Athens, GSK Investigational Site
- Athens, General Hospital of Athens "Evangelismos", Hematology Clinic
- Attica, Athens, Evaggelismos General Hospital
Trials:- NCT03215030 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT04398680 (Principal Investigator)
- NCT04891809 (Principal Investigator)
Conditions: -
SymeonidisSeen in:
- Patras, University General Hospital of Patras
Trials:- NCT05028348 (Principal Investigator)
Conditions:
Clinical Trials on Multiple Myeloma
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States